Full-Time

Vice President

Program & Portfolio Management Office, Pmo

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Medical technology for diagnostics and care

Healthcare

Compensation Overview

$207.9k - $374.2kAnnually

Expert

Sparks, MD, USA

This role is hybrid and must be based in Sparks, Maryland. At BD, hybrid means a minimum of four days a week in office.

Category
Project Management
Business & Strategy
Required Skills
Risk Management

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor's degree in Science, Engineering, Business Administration or a related field (Master's degree preferred)
  • Minimum 10 years of experience in program management, preferably within the medical device / life sciences industry
  • Proven track record of leading successful projects, demonstrating strong leadership and influencing skills
  • Excellent communication and interpersonal skills, with the ability to effectively communicate complex concepts to both technical and non-technical audiences
  • Strong analytical and problem-solving abilities, with the ability to think strategically and make sound decisions under pressure
  • Ability to manage multiple concurrent projects, prioritize tasks, and meet tight deadlines
  • Proficiency in project and resource management software and tools, such as Microsoft Project, OnePlan, etc.
Responsibilities
  • Develop and implement the overall strategy for the PMO, ensuring alignment with the company’s vision and goals
  • Oversee the entire R&D portfolio, leading teams managing our Molecular, Microbiology, and Point of Care platform portfolios
  • Manage a $150 million R&D budget, ensuring optimal allocation and utilization of funds
  • Partner with Business Unit leadership, R&D teams, and other stakeholders to ensure alignment and effective communication
  • Identify and mitigate risks associated with the R&D portfolio, ensuring predictable delivery of projects in line with business priorities
  • Establish and monitor key performance indicators (KPIs), delivering regular status updates to track the progress and success of projects
  • Lead, develop and mentor a team of program and portfolio managers, fostering a culture of excellence and continuous improvement.
Desired Qualifications
  • Knowledge of Agile methodologies and Scrum principles is desirable
  • Certification in Project Management Professional (PMP) or equivalent is advantageous

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...